Industry Research Reports
Home > Reports > Service & Software > Global Enterprise Immune System Market Insights, Forecast to 2031
Global Enterprise Immune System Market Insights, Forecast to 2031
Industry: Service & Software
Published Date: 2025-07-03
Pages: 151 Pages
Report ld: 4779623
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Enterprise Immune System Market Size(US$)
CAGR 2025-2031
24.6%
Market Size,2031
USD 9,444
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 2,524 million
Market Forecast in 2031(Value)
US$ 9,444 million
CAGR
24.6%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Enterprise Immune System market is projected to grow from US$ 2524 million in 2025 to US$ 9444 million by 2031, at a Compound Annual Growth Rate (CAGR) of 24.6% during the forecast period.
Enterprise Immune System (EIS) refers to a cybersecurity approach that uses advanced machine learning and AI techniques to mimic the human immune system’s ability to detect, learn from, and respond autonomously to threats within an enterprise network. Instead of relying solely on known threat signatures or rules, EIS continuously monitors network behavior to identify unusual activity, adapt to new threats, and contain attacks in real-time—helping organizations defend against sophisticated cyber threats.
The US & Canada market for Enterprise Immune System is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Enterprise Immune System is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Europe market for Enterprise Immune System is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key manufacturers of Enterprise Immune System include Darktrace, Vectra AI, Cylance, Exabeam, Microsoft, IBM Security, Splunk, CrowdStrike, Cisco, FireEye, etc. In 2024, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the Enterprise Immune System production, growth rate, market share by manufacturers and by region (region level and country level), from 2020 to 2025, and forecast to 2031.
In terms of consumption side, this report focuses on the sales of Enterprise Immune System by region (region level and country level), by company, by Type and by Application. from 2020 to 2025 and forecast to 2031.
This report presents an overview of global market for Enterprise Immune System, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2020 - 2025, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Enterprise Immune System, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Enterprise Immune System, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Enterprise Immune System sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Enterprise Immune System market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Enterprise Immune System sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Darktrace, Vectra AI, Cylance, Exabeam, Microsoft, IBM Security, Splunk, CrowdStrike, Cisco, FireEye, etc.
MARKET SEGMENTATION
By Company
- Darktrace
- Vectra AI
- Cylance
- Exabeam
- Microsoft
- IBM Security
- Splunk
- CrowdStrike
- Cisco
- FireEye
- Rapid7
- Securonix
- LogRhythm
- Proofpoint
- McAfee
- Fortinet
- Arctic Wolf
- Elastic Security
- Splunk Phantom
- SonicWall
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- On-Premise
- Cloud-Based
- Hybrid
Segment by Application
- Large Enterprises
- Small and Medium-sized Enterprises (SMEs)
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Enterprise Immune System production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Enterprise Immune System in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Enterprise Immune System manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: China by Type, and by Application, sales, and revenue for each segment.
Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Enterprise Immune System sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Enterprise Immune System Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 On-Premise
1.2.3 Cloud-Based
1.2.4 Hybrid
1.3 Market by Application
1.3.1 Global Enterprise Immune System Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Large Enterprises
1.3.3 Small and Medium-sized Enterprises (SMEs)
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Enterprise Immune System Market Perspective (2020-2031)
2.2 Global Enterprise Immune System Growth Trends by Region
2.2.1 Global Enterprise Immune System Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Enterprise Immune System Market Size by Region (2020-2031)
2.3 Enterprise Immune System Market Dynamics
2.3.1 Enterprise Immune System Industry Trends
2.3.2 Enterprise Immune System Market Drivers
2.3.3 Enterprise Immune System Market Challenges
2.3.4 Enterprise Immune System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Enterprise Immune System by Players
3.1.1 Global Enterprise Immune System Revenue by Players (2020-2025)
3.1.2 Global Enterprise Immune System Revenue Market Share by Players (2020-2025)
3.2 Global Enterprise Immune System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Enterprise Immune System, Ranking by Revenue, 2023 VS 2024 VS 2025
3.4 Global Market Concentration Ratio
3.4.1 Global Enterprise Immune System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Enterprise Immune System Revenue in 2024
3.5 Global Key Players of Enterprise Immune System Head office and Area Served
3.6 Global Key Players of Enterprise Immune System, Product and Application
3.7 Global Key Players of Enterprise Immune System, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Enterprise Immune System Historic Market Size by Type (2020-2025)
4.2 Global Enterprise Immune System Forecasted Market Size by Type (2026-2031)
5 Breakdown Data by Application
5.1 Global Enterprise Immune System Historic Market Size by Application (2020-2025)
5.2 Global Enterprise Immune System Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Enterprise Immune System Market Size (2020-2031)
6.2 North America Market Size by Type
6.2.1 North America Enterprise Immune System Market Size by Type (2020-2031)
6.2.2 North America Enterprise Immune System Market Share by Type (2020-2031)
6.3 North America Market Size by Application
6.3.1 North America Enterprise Immune System Market Size by Application (2020-2031)
6.3.2 North America Enterprise Immune System Market Share by Application (2020-2031)
6.4 North America Market Size by Country
6.4.1 North America Enterprise Immune System Market Size by Country: 2020 VS 2024 VS 2031
6.4.2 North America Enterprise Immune System Market Size by Country (2020-2031)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Enterprise Immune System Market Size (2020-2031)
7.2 Europe Market Size by Type
7.2.1 Europe Enterprise Immune System Market Size by Type (2020-2031)
7.2.2 Europe Enterprise Immune System Market Share by Type (2020-2031)
7.3 Europe Market Size by Application
7.3.1 Europe Enterprise Immune System Market Size by Application (2020-2031)
7.3.2 Europe Enterprise Immune System Market Share by Application (2020-2031)
7.4 Europe Market Size by Country
7.4.1 Europe Enterprise Immune System Market Size by Country: 2020 VS 2024 VS 2031
7.4.2 Europe Enterprise Immune System Market Size by Country (2020-2025)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Enterprise Immune System Market Size (2020-2031)
8.2 China Market Size by Type
8.2.1 China Enterprise Immune System Market Size by Type (2020-2031)
8.2.2 China Enterprise Immune System Market Share by Type (2020-2031)
8.3 China Market Size by Application
8.3.1 China Enterprise Immune System Market Size by Application (2020-2031)
8.3.2 China Enterprise Immune System Market Share by Application (2020-2031)
9 Asia (excluding China)
9.1 Asia Enterprise Immune System Market Size (2020-2031)
9.2 Asia Market Size by Type
9.2.1 Asia Enterprise Immune System Market Size by Type (2020-2031)
9.2.2 Asia Enterprise Immune System Market Share by Type (2020-2031)
9.3 Asia Market Size by Application
9.3.1 Asia Enterprise Immune System Market Size by Application (2020-2031)
9.3.2 Asia Enterprise Immune System Market Share by Application (2020-2031)
9.4 Asia Market Size by Region
9.4.1 Asia Enterprise Immune System Market Size by Region: 2020 VS 2024 VS 2031
9.4.2 Asia Enterprise Immune System Market Size by Region (2020-2031)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
9.4.8 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Enterprise Immune System Market Size (2020-2031)
10.2 Middle East, Africa, and Latin America Market Size by Type
10.2.1 Middle East, Africa, and Latin America Enterprise Immune System Market Size by Type (2020-2031)
10.2.2 Middle East, Africa, and Latin America Enterprise Immune System Market Share by Type (2020-2031)
10.3 Middle East, Africa, and Latin America Market Size by Application
10.3.1 Middle East, Africa, and Latin America Enterprise Immune System Market Size by Application (2020-2031)
10.3.2 Middle East, Africa, and Latin America Market Share by Application (2020-2031)
10.4 Middle East, Africa, and Latin America Market Size by Country
10.4.1 Middle East, Africa, and Latin America Enterprise Immune System Market Size by Country: 2020 VS 2024 VS 2031
10.4.2 Middle East, Africa, and Latin America Enterprise Immune System Market Size by Country (2020-2031)
10.4.3 Brazil
10.4.4 Mexico
10.4.5 Turkey
10.4.6 Saudi Arabia
10.4.7 Israel
10.4.8 GCC Countries
11 Key Players Profiles
11.1 Darktrace
11.1.1 Darktrace Company Details
11.1.2 Darktrace Business Overview
11.1.3 Darktrace Enterprise Immune System Introduction
11.1.4 Darktrace Revenue in Enterprise Immune System Business (2020-2025)
11.1.5 Darktrace Recent Development
11.2 Vectra AI
11.2.1 Vectra AI Company Details
11.2.2 Vectra AI Business Overview
11.2.3 Vectra AI Enterprise Immune System Introduction
11.2.4 Vectra AI Revenue in Enterprise Immune System Business (2020-2025)
11.2.5 Vectra AI Recent Development
11.3 Cylance
11.3.1 Cylance Company Details
11.3.2 Cylance Business Overview
11.3.3 Cylance Enterprise Immune System Introduction
11.3.4 Cylance Revenue in Enterprise Immune System Business (2020-2025)
11.3.5 Cylance Recent Development
11.4 Exabeam
11.4.1 Exabeam Company Details
11.4.2 Exabeam Business Overview
11.4.3 Exabeam Enterprise Immune System Introduction
11.4.4 Exabeam Revenue in Enterprise Immune System Business (2020-2025)
11.4.5 Exabeam Recent Development
11.5 Microsoft
11.5.1 Microsoft Company Details
11.5.2 Microsoft Business Overview
11.5.3 Microsoft Enterprise Immune System Introduction
11.5.4 Microsoft Revenue in Enterprise Immune System Business (2020-2025)
11.5.5 Microsoft Recent Development
11.6 IBM Security
11.6.1 IBM Security Company Details
11.6.2 IBM Security Business Overview
11.6.3 IBM Security Enterprise Immune System Introduction
11.6.4 IBM Security Revenue in Enterprise Immune System Business (2020-2025)
11.6.5 IBM Security Recent Development
11.7 Splunk
11.7.1 Splunk Company Details
11.7.2 Splunk Business Overview
11.7.3 Splunk Enterprise Immune System Introduction
11.7.4 Splunk Revenue in Enterprise Immune System Business (2020-2025)
11.7.5 Splunk Recent Development
11.8 CrowdStrike
11.8.1 CrowdStrike Company Details
11.8.2 CrowdStrike Business Overview
11.8.3 CrowdStrike Enterprise Immune System Introduction
11.8.4 CrowdStrike Revenue in Enterprise Immune System Business (2020-2025)
11.8.5 CrowdStrike Recent Development
11.9 Cisco
11.9.1 Cisco Company Details
11.9.2 Cisco Business Overview
11.9.3 Cisco Enterprise Immune System Introduction
11.9.4 Cisco Revenue in Enterprise Immune System Business (2020-2025)
11.9.5 Cisco Recent Development
11.10 FireEye
11.10.1 FireEye Company Details
11.10.2 FireEye Business Overview
11.10.3 FireEye Enterprise Immune System Introduction
11.10.4 FireEye Revenue in Enterprise Immune System Business (2020-2025)
11.10.5 FireEye Recent Development
11.11 Rapid7
11.11.1 Rapid7 Company Details
11.11.2 Rapid7 Business Overview
11.11.3 Rapid7 Enterprise Immune System Introduction
11.11.4 Rapid7 Revenue in Enterprise Immune System Business (2020-2025)
11.11.5 Rapid7 Recent Development
11.12 Securonix
11.12.1 Securonix Company Details
11.12.2 Securonix Business Overview
11.12.3 Securonix Enterprise Immune System Introduction
11.12.4 Securonix Revenue in Enterprise Immune System Business (2020-2025)
11.12.5 Securonix Recent Development
11.13 LogRhythm
11.13.1 LogRhythm Company Details
11.13.2 LogRhythm Business Overview
11.13.3 LogRhythm Enterprise Immune System Introduction
11.13.4 LogRhythm Revenue in Enterprise Immune System Business (2020-2025)
11.13.5 LogRhythm Recent Development
11.14 Proofpoint
11.14.1 Proofpoint Company Details
11.14.2 Proofpoint Business Overview
11.14.3 Proofpoint Enterprise Immune System Introduction
11.14.4 Proofpoint Revenue in Enterprise Immune System Business (2020-2025)
11.14.5 Proofpoint Recent Development
11.15 McAfee
11.15.1 McAfee Company Details
11.15.2 McAfee Business Overview
11.15.3 McAfee Enterprise Immune System Introduction
11.15.4 McAfee Revenue in Enterprise Immune System Business (2020-2025)
11.15.5 McAfee Recent Development
11.16 Fortinet
11.16.1 Fortinet Company Details
11.16.2 Fortinet Business Overview
11.16.3 Fortinet Enterprise Immune System Introduction
11.16.4 Fortinet Revenue in Enterprise Immune System Business (2020-2025)
11.16.5 Fortinet Recent Development
11.17 Arctic Wolf
11.17.1 Arctic Wolf Company Details
11.17.2 Arctic Wolf Business Overview
11.17.3 Arctic Wolf Enterprise Immune System Introduction
11.17.4 Arctic Wolf Revenue in Enterprise Immune System Business (2020-2025)
11.17.5 Arctic Wolf Recent Development
11.18 Elastic Security
11.18.1 Elastic Security Company Details
11.18.2 Elastic Security Business Overview
11.18.3 Elastic Security Enterprise Immune System Introduction
11.18.4 Elastic Security Revenue in Enterprise Immune System Business (2020-2025)
11.18.5 Elastic Security Recent Development
11.19 Splunk Phantom
11.19.1 Splunk Phantom Company Details
11.19.2 Splunk Phantom Business Overview
11.19.3 Splunk Phantom Enterprise Immune System Introduction
11.19.4 Splunk Phantom Revenue in Enterprise Immune System Business (2020-2025)
11.19.5 Splunk Phantom Recent Development
11.20 SonicWall
11.20.1 SonicWall Company Details
11.20.2 SonicWall Business Overview
11.20.3 SonicWall Enterprise Immune System Introduction
11.20.4 SonicWall Revenue in Enterprise Immune System Business (2020-2025)
11.20.5 SonicWall Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Enterprise Immune System Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of On-Premise
Table 3. Key Players of Cloud-Based
Table 4. Key Players of Hybrid
Table 5. Global Enterprise Immune System Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Enterprise Immune System Market Size Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Market Size by Region (2020-2031) & (US$ Million)
Table 8. Global Enterprise Immune System Market Share by Region (2020-2031)
Table 9. Market Trends
Table 10. Market Drivers
Table 11. Market Challenges
Table 12. Market Restraints
Table 13. Global Enterprise Immune System Revenue by Players (2020-2025) & (US$ Million)
Table 14. Global Enterprise Immune System Market Share by Players (2020-2025)
Table 15. Global Top Enterprise Immune System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enterprise Immune System as of 2024)
Table 16. Global Enterprise Immune System Industry Ranking 2023 VS 2024
Table 17. Global 5 Largest Players Market Share by Enterprise Immune System Revenue (CR5 and HHI) & (2020-2025)
Table 18. Global Key Players of Enterprise Immune System, Headquarters and Area Served
Table 19. Global Key Players of Enterprise Immune System, Product and Application
Table 20. Global Key Players of Enterprise Immune System, Date of Enter into This Industry
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global Market Size by Type (2020-2025) & (US$ Million)
Table 23. Global Enterprise Immune System Revenue Market Share by Type (2020-2025)
Table 24. Global Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 25. Global Enterprise Immune System Revenue Market Share by Type (2026-2031)
Table 26. Global Market Size by Application (2020-2025) & (US$ Million)
Table 27. Global Enterprise Immune System Revenue Market Share by Application (2020-2025)
Table 28. Global Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 29. Global Enterprise Immune System Revenue Market Share by Application (2026-2031)
Table 30. North America Market Size by Type (2020-2031) & (US$ Million)
Table 31. North America Market Size by Application (2020-2031) & (US$ Million)
Table 32. North America Enterprise Immune System Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Market Size by Country (2020-2031) & (US$ Million)
Table 34. Europe Market Size by Type (2020-2031) & (US$ Million)
Table 35. Europe Market Size by Application (2020-2031) & (US$ Million)
Table 36. Europe Enterprise Immune System Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Market Size by Country (2020-2025) & (US$ Million)
Table 38. China Market Size by Type (2020-2031) & (US$ Million)
Table 39. China Market Size by Application (2020-2031) & (US$ Million)
Table 40. Asia Market Size by Type (2020-2031) & (US$ Million)
Table 41. Asia Market Size by Application (2020-2025) & (US$ Million)
Table 42. Asia Enterprise Immune System Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031
Table 43. Asia Market Size by Region (2020-2031) & (US$ Million)
Table 44. Middle East, Africa, and Latin America Market Size by Type (2020-2031) & (US$ Million)
Table 45. Middle East, Africa, and Latin America Market Size by Application (2020-2031) & (US$ Million)
Table 46. Middle East, Africa, and Latin America Enterprise Immune System Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East, Africa, and Latin America Market Size by Country (2020-2031) & (US$ Million)
Table 48. Darktrace Company Details
Table 49. Darktrace Business Overview
Table 50. Darktrace Enterprise Immune System Product
Table 51. Darktrace Revenue (2020-2025) & (US$ Million)
Table 52. Darktrace Recent Development
Table 53. Vectra AI Company Details
Table 54. Vectra AI Business Overview
Table 55. Vectra AI Enterprise Immune System Product
Table 56. Vectra AI Revenue (2020-2025) & (US$ Million)
Table 57. Vectra AI Recent Development
Table 58. Cylance Company Details
Table 59. Cylance Business Overview
Table 60. Cylance Enterprise Immune System Product
Table 61. Cylance Revenue (2020-2025) & (US$ Million)
Table 62. Cylance Recent Development
Table 63. Exabeam Company Details
Table 64. Exabeam Business Overview
Table 65. Exabeam Enterprise Immune System Product
Table 66. Exabeam Revenue (2020-2025) & (US$ Million)
Table 67. Exabeam Recent Development
Table 68. Microsoft Company Details
Table 69. Microsoft Business Overview
Table 70. Microsoft Enterprise Immune System Product
Table 71. Microsoft Revenue (2020-2025) & (US$ Million)
Table 72. Microsoft Recent Development
Table 73. IBM Security Company Details
Table 74. IBM Security Business Overview
Table 75. IBM Security Enterprise Immune System Product
Table 76. IBM Security Revenue (2020-2025) & (US$ Million)
Table 77. IBM Security Recent Development
Table 78. Splunk Company Details
Table 79. Splunk Business Overview
Table 80. Splunk Enterprise Immune System Product
Table 81. Splunk Revenue (2020-2025) & (US$ Million)
Table 82. Splunk Recent Development
Table 83. CrowdStrike Company Details
Table 84. CrowdStrike Business Overview
Table 85. CrowdStrike Enterprise Immune System Product
Table 86. CrowdStrike Revenue (2020-2025) & (US$ Million)
Table 87. CrowdStrike Recent Development
Table 88. Cisco Company Details
Table 89. Cisco Business Overview
Table 90. Cisco Enterprise Immune System Product
Table 91. Cisco Revenue (2020-2025) & (US$ Million)
Table 92. Cisco Recent Development
Table 93. FireEye Company Details
Table 94. FireEye Business Overview
Table 95. FireEye Enterprise Immune System Product
Table 96. FireEye Revenue (2020-2025) & (US$ Million)
Table 97. FireEye Recent Development
Table 98. Rapid7 Company Details
Table 99. Rapid7 Business Overview
Table 100. Rapid7 Enterprise Immune System Product
Table 101. Rapid7 Revenue (2020-2025) & (US$ Million)
Table 102. Rapid7 Recent Development
Table 103. Securonix Company Details
Table 104. Securonix Business Overview
Table 105. Securonix Enterprise Immune System Product
Table 106. Securonix Revenue (2020-2025) & (US$ Million)
Table 107. Securonix Recent Development
Table 108. LogRhythm Company Details
Table 109. LogRhythm Business Overview
Table 110. LogRhythm Enterprise Immune System Product
Table 111. LogRhythm Revenue (2020-2025) & (US$ Million)
Table 112. LogRhythm Recent Development
Table 113. Proofpoint Company Details
Table 114. Proofpoint Business Overview
Table 115. Proofpoint Enterprise Immune System Product
Table 116. Proofpoint Revenue (2020-2025) & (US$ Million)
Table 117. Proofpoint Recent Development
Table 118. McAfee Company Details
Table 119. McAfee Business Overview
Table 120. McAfee Enterprise Immune System Product
Table 121. McAfee Revenue (2020-2025) & (US$ Million)
Table 122. McAfee Recent Development
Table 123. Fortinet Company Details
Table 124. Fortinet Business Overview
Table 125. Fortinet Enterprise Immune System Product
Table 126. Fortinet Revenue (2020-2025) & (US$ Million)
Table 127. Fortinet Recent Development
Table 128. Arctic Wolf Company Details
Table 129. Arctic Wolf Business Overview
Table 130. Arctic Wolf Enterprise Immune System Product
Table 131. Arctic Wolf Revenue (2020-2025) & (US$ Million)
Table 132. Arctic Wolf Recent Development
Table 133. Elastic Security Company Details
Table 134. Elastic Security Business Overview
Table 135. Elastic Security Enterprise Immune System Product
Table 136. Elastic Security Revenue (2020-2025) & (US$ Million)
Table 137. Elastic Security Recent Development
Table 138. Splunk Phantom Company Details
Table 139. Splunk Phantom Business Overview
Table 140. Splunk Phantom Enterprise Immune System Product
Table 141. Splunk Phantom Revenue (2020-2025) & (US$ Million)
Table 142. Splunk Phantom Recent Development
Table 143. SonicWall Company Details
Table 144. SonicWall Business Overview
Table 145. SonicWall Enterprise Immune System Product
Table 146. SonicWall Revenue (2020-2025) & (US$ Million)
Table 147. SonicWall Recent Development
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Enterprise Immune System Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 2. Global Enterprise Immune System Market Share by Type: 2024 VS 2031
Figure 3. On-Premise Features
Figure 4. Cloud-Based Features
Figure 5. Hybrid Features
Figure 6. Global Enterprise Immune System Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Global Enterprise Immune System Market Share by Application: 2024 VS 2031
Figure 8. Large Enterprises Case Studies
Figure 9. Small and Medium-sized Enterprises (SMEs) Case Studies
Figure 10. Enterprise Immune System Report Years Considered
Figure 11. Global Enterprise Immune System Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Enterprise Immune System Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Enterprise Immune System Market Share by Region: 2024 VS 2031
Figure 14. Global Enterprise Immune System Market Share by Players in 2024
Figure 15. Global Top Enterprise Immune System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enterprise Immune System as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Enterprise Immune System Revenue in 2024
Figure 17. North America Enterprise Immune System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Enterprise Immune System Market Share by Type (2020-2031)
Figure 19. North America Enterprise Immune System Market Share by Application (2020-2031)
Figure 20. North America Enterprise Immune System Market Share by Country (2020-2031)
Figure 21. United States Enterprise Immune System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Enterprise Immune System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Enterprise Immune System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Enterprise Immune System Market Share by Type (2020-2031)
Figure 25. Europe Enterprise Immune System Market Share by Application (2020-2031)
Figure 26. Europe Enterprise Immune System Market Share by Country (2020-2031)
Figure 27. Germany Enterprise Immune System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Enterprise Immune System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Enterprise Immune System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Enterprise Immune System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Enterprise Immune System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Enterprise Immune System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. China Enterprise Immune System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. China Enterprise Immune System Market Share by Type (2020-2031)
Figure 35. China Enterprise Immune System Market Share by Application (2020-2031)
Figure 36. Asia Enterprise Immune System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia Enterprise Immune System Market Share by Type (2020-2031)
Figure 38. Asia Enterprise Immune System Market Share by Application (2020-2031)
Figure 39. Asia Enterprise Immune System Market Share by Region (2020-2031)
Figure 40. Japan Enterprise Immune System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. South Korea Enterprise Immune System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. China Taiwan Enterprise Immune System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Southeast Asia Enterprise Immune System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. India Enterprise Immune System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Australia Enterprise Immune System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Enterprise Immune System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Enterprise Immune System Market Share by Type (2020-2031)
Figure 48. Middle East, Africa, and Latin America Enterprise Immune System Market Share by Application (2020-2031)
Figure 49. Middle East, Africa, and Latin America Enterprise Immune System Market Share by Country (2020-2031)
Figure 50. Brazil Enterprise Immune System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Mexico Enterprise Immune System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Turkey Enterprise Immune System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Enterprise Immune System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. Israel Enterprise Immune System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 55. GCC Countries Enterprise Immune System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 56. Darktrace Revenue Growth Rate in Enterprise Immune System Business (2020-2025)
Figure 57. Vectra AI Revenue Growth Rate in Enterprise Immune System Business (2020-2025)
Figure 58. Cylance Revenue Growth Rate in Enterprise Immune System Business (2020-2025)
Figure 59. Exabeam Revenue Growth Rate in Enterprise Immune System Business (2020-2025)
Figure 60. Microsoft Revenue Growth Rate in Enterprise Immune System Business (2020-2025)
Figure 61. IBM Security Revenue Growth Rate in Enterprise Immune System Business (2020-2025)
Figure 62. Splunk Revenue Growth Rate in Enterprise Immune System Business (2020-2025)
Figure 63. CrowdStrike Revenue Growth Rate in Enterprise Immune System Business (2020-2025)
Figure 64. Cisco Revenue Growth Rate in Enterprise Immune System Business (2020-2025)
Figure 65. FireEye Revenue Growth Rate in Enterprise Immune System Business (2020-2025)
Figure 66. Rapid7 Revenue Growth Rate in Enterprise Immune System Business (2020-2025)
Figure 67. Securonix Revenue Growth Rate in Enterprise Immune System Business (2020-2025)
Figure 68. LogRhythm Revenue Growth Rate in Enterprise Immune System Business (2020-2025)
Figure 69. Proofpoint Revenue Growth Rate in Enterprise Immune System Business (2020-2025)
Figure 70. McAfee Revenue Growth Rate in Enterprise Immune System Business (2020-2025)
Figure 71. Fortinet Revenue Growth Rate in Enterprise Immune System Business (2020-2025)
Figure 72. Arctic Wolf Revenue Growth Rate in Enterprise Immune System Business (2020-2025)
Figure 73. Elastic Security Revenue Growth Rate in Enterprise Immune System Business (2020-2025)
Figure 74. Splunk Phantom Revenue Growth Rate in Enterprise Immune System Business (2020-2025)
Figure 75. SonicWall Revenue Growth Rate in Enterprise Immune System Business (2020-2025)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Enterprise Immune System in 2031?
The global market size of Enterprise Immune System in 2031 was 9444 Million USD.
What is the annual compound growth rate of the global Enterprise Immune System market size from 2025 to 2031?
What was the global market size of Enterprise Immune System in 2025?
Which companies rank high in the global Enterprise Immune System market?
Which region is expected to have the highest market share?
Related Reports
Global Enterprise Immune System Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Enterprise Immune System market is projected to grow from US$ 2524 million in 2025 to US$ 11530 million by 2032, at a CAGR of 24.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-12
Pages: 154
USD 4900.00
(Single User License)
Global Enterprise Immune System Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Enterprise Immune System market size was US$ 2524 million in 2025 and is forecast to reach a readjusted size of US$ 11530 million by 2032 with a CAGR of 24.6% during the forecast period 2026-2032.
Published Date: 2026-03-12
Pages: 103
USD 4250.00
(Single User License)
Global Enterprise Immune System Market Research Report 2026
The global Enterprise Immune System market was valued at US$ 2524 million in 2025 and is anticipated to reach US$ 11530 million by 2032, at a CAGR of 24.6% from 2026 to 2032.
Published Date: 2026-03-12
Pages: 131
USD 2900.00
(Single User License)
Enterprise Immune System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Enterprise Immune System was estimated to be worth US$ 2524 million in 2025 and is projected to reach US$ 11530 million, growing at a CAGR of 24.6% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 123
USD 3950.00
(Single User License)
Global Enterprise Immune System Market Research Report 2025
The global market for Enterprise Immune System was valued at US$ 2026 million in the year 2024 and is projected to reach a revised size of US$ 9444 million by 2031, growing at a CAGR of 24.6% during the forecast period.
Published Date: 2025-07-03
Pages: 92
USD 2900.00
(Single User License)
Enterprise Immune System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Enterprise Immune System was estimated to be worth US$ 2026 million in 2024 and is forecast to a readjusted size of US$ 9444 million by 2031 with a CAGR of 24.6% during the forecast period 2025-2031.
Published Date: 2025-07-03
Pages: 128
USD 3950.00
(Single User License)
Global Enterprise Immune System Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Enterprise Immune System market size was US$ 2026 million in 2024 and is forecast to a readjusted size of US$ 9444 million by 2031 with a CAGR of 24.6% during the forecast period 2025-2031.
Published Date: 2025-07-03
Pages: 105
USD 4250.00
(Single User License)
Global Enterprise Immune System Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Enterprise Immune System market is projected to grow from US$ 2524 million in 2025 to US$ 11530 million by 2032, at a CAGR of 24.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-12
Pages: 154
USD 4900.00 (Single User License)Global Enterprise Immune System Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Enterprise Immune System market size was US$ 2524 million in 2025 and is forecast to reach a readjusted size of US$ 11530 million by 2032 with a CAGR of 24.6% during the forecast period 2026-2032.
Published: 2026-03-12
Pages: 103
USD 4250.00 (Single User License)Global Enterprise Immune System Market Research Report 2026
The global Enterprise Immune System market was valued at US$ 2524 million in 2025 and is anticipated to reach US$ 11530 million by 2032, at a CAGR of 24.6% from 2026 to 2032.
Published: 2026-03-12
Pages: 131
USD 2900.00 (Single User License)Enterprise Immune System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Enterprise Immune System was estimated to be worth US$ 2524 million in 2025 and is projected to reach US$ 11530 million, growing at a CAGR of 24.6% from 2026 to 2032.
Published: 2026-03-09
Pages: 123
USD 3950.00 (Single User License)Global Enterprise Immune System Market Research Report 2025
The global market for Enterprise Immune System was valued at US$ 2026 million in the year 2024 and is projected to reach a revised size of US$ 9444 million by 2031, growing at a CAGR of 24.6% during the forecast period.
Published: 2025-07-03
Pages: 92
USD 2900.00 (Single User License)Enterprise Immune System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Enterprise Immune System was estimated to be worth US$ 2026 million in 2024 and is forecast to a readjusted size of US$ 9444 million by 2031 with a CAGR of 24.6% during the forecast period 2025-2031.
Published: 2025-07-03
Pages: 128
USD 3950.00 (Single User License)Global Enterprise Immune System Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Enterprise Immune System market size was US$ 2026 million in 2024 and is forecast to a readjusted size of US$ 9444 million by 2031 with a CAGR of 24.6% during the forecast period 2025-2031.
Published: 2025-07-03
Pages: 105
USD 4250.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now